Infection and the chronic wound: a focus on silver.
Warriner
Robert
R
Praxis Clinical Services, Anaheim, CA, USA.
Burrell
Robert
R
D000287:Administration, Topical; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001424:Bacterial Infections / Q000175:diagnosis / Q000628:therapy*; D002908:Chronic Disease; D003131:Combined Modality Therapy; D003646:Debridement / Q000379:methods; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D018570:Risk Assessment; D012720:Severity of Illness Index; D012837:Silver Sulfadiazine / Q000627:therapeutic use*; D016896:Treatment Outcome; D014945:Wound Healing / Q000187:drug effects / Q000502:physiology; D014946:Wound Infection / Q000453:epidemiology / Q000382:microbiology* / Q000628:therapy*; D014947:Wounds and Injuries / Q000150:complications* / Q000175:diagnosis
D000900:Anti-Bacterial Agents; D012837:Silver Sulfadiazine